Literature DB >> 9849662

Activation and desensitization properties of native and recombinant kainate receptors.

A V Paternain1, A Rodríguez-Moreno, A Villarroel, J Lerma.   

Abstract

The activation-inactivation properties of membrane currents induced by the rapid application of glutamate or kainate were studied in cultured hippocampal neurons and in HEK cells transfected with a cDNA encoding the GluR6 subunit. The onset of desensitization was rapid and similar in native and recombinant channels (approximately 80 s(-1) of onset rate constant). Recovery from desensitization was slow and agonist-dependent in neurons, proceeding slightly faster in GluR6 receptors. Half-maximal activation (EC50) of native channels was obtained at a glutamate concentration of 330 microM, while the half-maximal steady state desensitization (IC1/2) was attained at 2.8 microM. These values differed from those obtained in recombinant receptors (EC50 = 762 microM and IC1/2 = 0.44 microM). A small window under the crossing point of activation and inactivation curves was observed, indicating that, for some concentrations of either agonist, steady state channel activity could exist. In native receptors, this window presented maximum values at approximately 100 microM for glutamate, which predicted well the potency of glutamate to reduce the GABAergic drive in hippocampal slices. These data indicate that for neuronal kainate receptors, the concentrations for half activation and half inactivation differ by two orders of magnitude such that the maximum response to a maintained concentration of glutamate is small, and the steady state dose response curve is skewed and bell shaped.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849662     DOI: 10.1016/s0028-3908(98)00098-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  33 in total

1.  Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons.

Authors:  A Rodríguez-Moreno; J C López-García; J Lerma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse.

Authors:  H Kamiya; S Ozawa
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

3.  GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors.

Authors:  A V Paternain; M T Herrera; M A Nieto; J Lerma
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Functional stoichiometry of glutamate receptor desensitization.

Authors:  Derek Bowie; G David Lange
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

5.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

6.  Attenuated plasticity of postsynaptic kainate receptors in hippocampal CA3 pyramidal neurons.

Authors:  Koichi Ito; Anis Contractor; Geoffrey T Swanson
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

7.  The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.

Authors:  Janet L Fisher
Journal:  Neuropharmacology       Date:  2015-08-13       Impact factor: 5.250

8.  Concanavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptor.

Authors:  Anne-Marie L Fay; Derek Bowie
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

9.  Autoinactivation of neuronal AMPA receptors via glutamate-regulated TARP interaction.

Authors:  Megumi Morimoto-Tomita; Wei Zhang; Christoph Straub; Chang-Hoon Cho; Kwang S Kim; James R Howe; Susumu Tomita
Journal:  Neuron       Date:  2009-01-15       Impact factor: 17.173

10.  Subunit-dependent postsynaptic expression of kainate receptors on hippocampal interneurons in area CA1.

Authors:  Joyce Wondolowski; Matthew Frerking
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.